Adverse Events in Pregnant Patients Treated with Coronavirus Disease 2019 Therapeutics.
Mark SimonJennie A BuchananJonathan SchimmelJeffrey BrentKeith BurkhartPaul WaxNatalie TaylorKim Aldynull nullPublished in: Journal of medical toxicology : official journal of the American College of Medical Toxicology (2023)
This case series reports AEs of elevated serum alanine aminotransferase, maternal bradycardia, maternal hypothermia, non-reassuring fetal heart patterns, and emergent or unplanned cesarean sections following administration of several COVID-19 therapeutics. This study was not designed to definitely identify causation, and further study is needed to evaluate the causal role of these therapeutics in AEs affecting pregnant COVID-19 patients.